课题基金 / 基金详情

项目摘要

项目成果

William Robert Taylor的其他基金

相似基金

相关文献

中文摘要
翻译
描述(由申请人提供):本提案是为了继续支持我们的生物工程研究伙伴关系,题为生物学,生物力学和动脉粥样硬化。在我们BRP资助的前4年,我们的团队专注于更好地了解动脉粥样硬化的基本机制,特别关注生物力学力和动脉粥样硬化之间的相互关系。我们最初的努力范围广泛,结合了来自广泛的临床和学术领域的工程师,生物学家和临床医生的专业知识。在这方面,我们要求继续支持,我们选择将我们的努力集中在一个单一的动脉粥样硬化疾病实体,腹主动脉瘤(AAA)。我们采取这种方法是基于几个因素,包括临床问题的重要性,BRP成员开发的广泛的相关初步数据,以及BRP成员更加关注的潜在好处。 本BRP的总体目标是更好地了解AAA形成的生物学和生物力学,总体目标是获得对AAA发展潜在机制的新见解。这个项目是支持我的新的数据,从这个BRP的成员,牵连额外的蛋白质家族在适应不良的主动脉壁的重塑,发生在AAA的形成。该提案将侧重于在重塑的最早阶段发展动脉瘤,以便研究AAA形成的最生物学相关方面。
英文摘要
DESCRIPTION (provided by applicant): This proposal is for continued support of our Bioengineering Research Partnership entitled Biology, Biomechanics and Atherosclerosis. Over the first 4 years of our BRP funding, our group has focused on obtaining a better understanding of the basic mechanism of atherosclerosis with a particular focus on the interrelationships between biomechanical forces and atherosclerosis. Our initial efforts have been broad in scope incorporating the expertise of engineers, biologists and clinicians from an expansive range of clinical and academic areas. In this, our request for continued support, we have elected to focus our efforts on a single atherosclerotic disease entity, abdominal aortic aneurysms (AAA). We have taken this approach based on several factors including the importance of the clinical problem, the development of extensive, relevant preliminary data by members of the BRP and the potential benefit of having a greater focus for the members of the BRP. The overall goal of this BRP is to gain a better understanding of the biology and biomechanics of AAA formation with the overall goal of gaining new insights into the underlying mechanisms of AAA development. This project is support my novel data from the members of this BRP that implicate additional protein families in the maladaptive remodeling of the aortic wall that occurs during AAA formation. This proposal will focus on developing aneurysms at the earliest stages of remodeling so as to study the most biologically relevant aspects of AAA formation.
期刊论文(49)
专著(0)
科研奖励(0)
会议论文
Preferential activation of SMAD1/5/8 on the fibrosa endothelium in calcified human aortic valves--association with low BMP antagonists and SMAD6.
钙化人主动脉瓣纤维内皮上 SMAD1/5/8 的优先激活——与低 BMP 拮抗剂和 SMAD6 的关联。
DOI: 10.1371/journal.pone.0020969
发表时间: 2011
期刊: PloS one
影响因子: 3.7
作者: [Ankeny RF, Thourani VH, Weiss D, Vega JD, Taylor WR, Nerem RM, Jo H]
通讯作者: Jo H
DOI: 10.1586/erc.10.28
发表时间: 2010-04
期刊: Expert review of cardiovascular therapy
影响因子: 2
作者: [Dhawan SS, Avati Nanjundappa RP, Branch JR, Taylor WR, Quyyumi AA, Jo H, McDaniel MC, Suo J, Giddens D, Samady H]
通讯作者: Samady H
DOI: 10.1007/s10439-012-0727-9
发表时间: 2013
期刊: Annals of biomedical engineering
影响因子: 3.8
作者: [Rachev,Alexander, Taylor,WRobert, Vito,RaymondP]
通讯作者: Vito,RaymondP
DOI: 10.1007/s13239-013-0165-3
发表时间: 2013-12
期刊: CARDIOVASCULAR ENGINEERING AND TECHNOLOGY
影响因子: 1.8
作者: [Campbell, Ian C, Timmins, Lucas H, Giddens, Don P, Virmani, Renu, Veneziani, Alessandro, Rab, S Tanveer, Samady, Habib, McDaniel, Michael C, Finn, Aloke V, Taylor, W Robert, Oshinski, John N]
通讯作者: Oshinski, John N
共 26 条
    HOWARD UNIVERSITY GENERAL CLINICAL RESEARCH CENTER
    • 批准号:
      8167000
    • 项目类别:
    • 资助金额:
      $0.0万
    • 财政年份:
      2010
    • 负责人:
      William Robert Taylor
    • 依托单位:
    Biology, Biomechanics and Atherosclerosis
    • 批准号:
      7822529
    • 项目类别:
    • 资助金额:
      $1.86万
    • 财政年份:
      2009
    • 负责人:
      William Robert Taylor
    • 依托单位:
    Osteopontin and Collateral Vessel Growth
    • 批准号:
      7731048
    • 项目类别:
    • 资助金额:
      $36.17万
    • 财政年份:
      2009
    • 负责人:
      William Robert Taylor
    • 依托单位:
    Catalase: a pivotal regulator of vascular disease
    • 批准号:
      9271227
    • 项目类别:
    • 资助金额:
      $33.53万
    • 财政年份:
      2009
    • 负责人:
      William Robert Taylor
    • 依托单位:
    国内基金
    海外基金
    补阳还五汤通过AGE-RAGE通路调控脓毒症免疫失衡的机制与转化研究
    靶向递送一氧化碳调控AGE-RAGE级联反应促进糖尿病创面愈合研究
    • 批准号:
      JCZRQN202500010
    • 项目类别:
      省市级项目
    • 资助金额:
      --
    • 批准年份:
      2025
    • 负责人:
    • 依托单位:
    对香豆酸抑制AGE-RAGE-Ang-1通路改善海马血管生成障碍发挥抗阿尔兹海默病作用
    • 批准号:
      2025JJ70209
    • 项目类别:
      省市级项目
    • 资助金额:
      --
    • 批准年份:
      2025
    • 负责人:
      雷芬芳
    • 依托单位:
    AGE-RAGE通路调控慢性胰腺炎纤维化进程的作用及分子机制
    • 批准号:
      --
    • 项目类别:
      面上项目
    • 资助金额:
      --
    • 批准年份:
      2024
    • 负责人:
      万荣
    • 依托单位: